Life Stem Genetics Inc.; Order of Suspension of Trading, 71021 [2013-28607]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 229 / Wednesday, November 27, 2013 / Notices
At any time within 60 days of the
filing of such proposed rule change, the
Commission summarily may
temporarily suspend such rule change if
it appears to the Commission that such
action is necessary or appropriate in the
public interest, for the protection of
investors, or otherwise in furtherance of
the purposes of the Act. If the
Commission takes such action, the
Commission shall institute proceedings
under Section 19(b)(2)(B) 23 of the Act to
determine whether the proposed rule
change should be approved or
disapproved.
IV. Solicitation of Comments
Interested persons are invited to
submit written data, views, and
arguments concerning the foregoing,
including whether the proposed rule
change is consistent with the Act.
Comments may be submitted by any of
the following methods:
emcdonald on DSK67QTVN1PROD with NOTICES
Electronic Comments
• Use the Commission’s Internet
comment form (https://www.sec.gov/
rules/sro.shtml); or
• Send an email to rule-comments@
sec.gov. Please include File Number SR–
NASDAQ–2013–140 on the subject line.
Paper Comments
• Send paper comments in triplicate
to Elizabeth M. Murphy, Secretary,
Securities and Exchange Commission,
100 F Street NE., Washington, DC
20549–1090.
All submissions should refer to File
Number SR–NASDAQ–2013–140. This
file number should be included on the
subject line if email is used. To help the
Commission process and review your
comments more efficiently, please use
only one method. The Commission will
post all comments on the Commission’s
Internet Web site (https://www.sec.gov/
rules/sro.shtml). Copies of the
submission, all subsequent
amendments, all written statements
with respect to the proposed rule
change that are filed with the
Commission, and all written
communications relating to the
proposed rule change between the
Commission and any person, other than
those that may be withheld from the
public in accordance with the
provisions of 5 U.S.C. 552, will be
available for Web site viewing and
printing in the Commission’s Public
Reference Room, 100 F Street NE.,
Washington, DC 20549, on official
business days between the hours of
10:00 a.m. and 3:00 p.m. Copies of the
filing also will be available for
23 15
U.S.C. 78s(b)(2)(B).
VerDate Mar<15>2010
17:02 Nov 26, 2013
inspection and copying at the principal
office of the Exchange. All comments
received will be posted without change;
the Commission does not edit personal
identifying information from
submissions. You should submit only
information that you wish to make
available publicly. All submissions
should refer to File Number SR–
NASDAQ–2013–140 and should be
submitted on or before December 18,
2013.
For the Commission, by the Division of
Trading and Markets, pursuant to delegated
authority.24
Kevin M. O’Neill,
Deputy Secretary.
[FR Doc. 2013–28420 Filed 11–26–13; 8:45 am]
BILLING CODE 8011–01–P
SECURITIES AND EXCHANGE
COMMISSION
[File No. 500–1]
Life Stem Genetics Inc.; Order of
Suspension of Trading
November 25, 2013.
It appears to the Securities and
Exchange Commission that there is a
lack of current and accurate information
concerning the securities of Life Stem
Genetics Inc. because of questions
regarding the accuracy of assertions by
the company, and by others, including
in press releases to investors
concerning, among other things, the
company’s operations.
The Commission is of the opinion that
the public interest and the protection of
investors require a suspension of trading
in the securities of the above-listed
company.
Therefore, it is ordered, pursuant to
Section 12(k) of the Securities Exchange
Act of 1934, that trading in the
securities of the above-listed company is
suspended for the period from 9:30 a.m.
EST, on November 25, 2013 through
11:59 p.m. EST, on December 9, 2013.
By the Commission.
Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2013–28607 Filed 11–25–13; 11:15 am]
BILLING CODE 8011–01–P
24 17
Jkt 232001
PO 00000
CFR 200.30–3(a)(12).
Frm 00107
Fmt 4703
Sfmt 4703
71021
DEPARTMENT OF STATE
[Public Notice 8530]
Certification Under the Department of
State, Foreign Operations, and Related
Programs Appropriations Act
Certification Pursuant to Section
7041(a) of the Department of State,
Foreign Operations, and Related
Programs Appropriations Act, 2012
(DIV. I, Pub. L. 112–74) as Carried
Forward by the Full Year Continuing
Appropriations Act, 2013 (DIV. F, Pub.
L. 113–6)
By virtue of the authority vested in
me as Secretary of State pursuant to
section 7041(a) of the Department of
State, Foreign Operations, and Related
Programs Appropriations Act, 2012
(Div. I, Pub. L. 112–74), as carried
forward by the Full Year Continuing
Appropriations Act, 2013 (Div. F, Pub.
L. 113–6), I hereby certify that the
Government of Egypt is meeting its
obligations under the 1979 Egypt-Israel
Peace Treaty.
This determination shall be published
in the Federal Register and, along with
the accompanying Memorandum of
Justification, shall be reported to
Congress.
Dated: May 3, 2013.
John F. Kerry,
Secretary of State.
Editorial Note: This document arrived at
the Federal Register on November 20, 2013.
[FR Doc. 2013–28227 Filed 11–26–13; 8:45 am]
BILLING CODE 4710–31–P
DEPARTMENT OF STATE
[Public Notice 8536]
Culturally Significant Objects Imported
for Exhibition Determinations:
‘‘Antonio Canova: The Seven Last
Works’’
Notice is hereby given of the
following determinations: Pursuant to
the authority vested in me by the Act of
October 19, 1965 (79 Stat. 985; 22 U.S.C.
2459), Executive Order 12047 of March
27, 1978, the Foreign Affairs Reform and
Restructuring Act of 1998 (112 Stat.
2681, et seq.; 22 U.S.C. 6501 note, et
seq.), Delegation of Authority No. 234 of
October 1, 1999, Delegation of Authority
No. 236–3 of August 28, 2000 (and, as
appropriate, Delegation of Authority No.
257 of April 15, 2003), I hereby
determine that the objects to be
included in the exhibition ‘‘Antonio
Canova: The Seven Last Works,’’
imported from abroad for temporary
exhibition within the United States, are
SUMMARY:
E:\FR\FM\27NON1.SGM
27NON1
]]>Agencies
[Federal Register Volume 78, Number 229 (Wednesday, November 27, 2013)]
[Notices]
[Page 71021]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-28607]
-----------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
[File No. 500-1]
Life Stem Genetics Inc.; Order of Suspension of Trading
November 25, 2013.
It appears to the Securities and Exchange Commission that there is
a lack of current and accurate information concerning the securities of
Life Stem Genetics Inc. because of questions regarding the accuracy of
assertions by the company, and by others, including in press releases
to investors concerning, among other things, the company's operations.
The Commission is of the opinion that the public interest and the
protection of investors require a suspension of trading in the
securities of the above-listed company.
Therefore, it is ordered, pursuant to Section 12(k) of the
Securities Exchange Act of 1934, that trading in the securities of the
above-listed company is suspended for the period from 9:30 a.m. EST, on
November 25, 2013 through 11:59 p.m. EST, on December 9, 2013.
By the Commission.
Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2013-28607 Filed 11-25-13; 11:15 am]
BILLING CODE 8011-01-P
